Search
for

    Research 10 of 286

    1. Advances in nucleoside monophosphate prodrugs as anti-HCV agents Antiviral Therapy · 2010 · 52 citations
    2. Medications Altering Sex Hormone Balance and Risk of Advanced Liver Disease in HCV-infected Males The American Journal of Gastroenterology · 2011
    3. Tu1491 – Use of Androgen Lowering Medications Finasteride and Dutasteride Do Not Substantially Alter Risk of Incident Hcvrelated Hepatcellular Carcinoma in Men Gastroenterology · 2019
    4. Dermatological Manifestations of Pegylated Interferon alfa2a and Ribavirin Combination Therapy in Chronic HCV Patients Afro-Egyptian Journal of Infectious and Endemic Diseases · 2016
    5. Lichenoid dermatitis from interferon alpha-2a in a patient with metastatic renal cell carcinoma and seronegative HCV Journal of The American Academy of Dermatology · 2016 · 4 citations
    6. Cutaneous and Mucosal Lichen Planus: A Comprehensive Review of Clinical Subtypes, Risk Factors, Diagnosis, and Prognosis The Scientific World Journal · 2014 · 291 citations
    7. Reversible alopecia universalis secondary to PEG-interferon ??-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection European Journal of Gastroenterology & Hepatology · 2007 · 41 citations
    8. Familial and Sporadic Porphyria Cutanea Tarda Medicine · 2010 · 38 citations
    9. High dose interferon treatment in chronic hepatitis C. Gut · 1993 · 36 citations
    10. Lichen planus and other cutaneous manifestations in chronic hepatitis C: pre- and post-interferon-based treatment prevalence vary in a cohort of patients from low hepatitis C virus endemic area Journal of the European Academy of Dermatology and Venereology · 2008 · 34 citations
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →